Short Interest in Vicarious Surgical Inc. (NYSE:RBOT) Increases By 37.4%

Vicarious Surgical Inc. (NYSE:RBOT) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 207,502 shares, a growth of 37.4% from the November 30th total of 151,012 shares. Based on an average daily trading volume, of 219,487 shares, the short-interest ratio is currently 0.9 days. Currently, 3.5% of the company’s shares are sold short. Currently, 3.5% of the company’s shares are sold short. Based on an average daily trading volume, of 219,487 shares, the short-interest ratio is currently 0.9 days.

Wall Street Analyst Weigh In

Several analysts recently commented on RBOT shares. Wall Street Zen raised Vicarious Surgical to a “sell” rating in a research note on Saturday, September 13th. Weiss Ratings restated a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, October 8th. Finally, BTIG Research reaffirmed a “neutral” rating on shares of Vicarious Surgical in a research report on Friday, December 12th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $7.00.

Institutional Trading of Vicarious Surgical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. DNB Asset Management AS lifted its stake in Vicarious Surgical by 12.1% in the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after acquiring an additional 3,154 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Vicarious Surgical by 22.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after purchasing an additional 3,615 shares during the last quarter. Finally, Connective Capital Management LLC bought a new stake in shares of Vicarious Surgical in the 3rd quarter valued at about $169,000. 47.27% of the stock is owned by institutional investors.

Vicarious Surgical Price Performance

RBOT stock traded down $0.01 during trading hours on Tuesday, reaching $1.87. 105,507 shares of the stock were exchanged, compared to its average volume of 54,766. The firm’s 50-day moving average is $3.47 and its 200-day moving average is $6.05. The company has a market cap of $12.25 million, a price-to-earnings ratio of -0.21 and a beta of 1.51. Vicarious Surgical has a 12 month low of $1.81 and a 12 month high of $18.97.

Vicarious Surgical (NYSE:RBOT) last issued its quarterly earnings results on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, beating analysts’ consensus estimates of ($2.37) by $0.46. As a group, equities research analysts forecast that Vicarious Surgical will post -10.89 earnings per share for the current year.

Vicarious Surgical Company Profile

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.